JEANETTE DRESSEL: Open Payments
NPI 1942265574 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,779 in 107 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $2,147 · 2025 $2,779
Food & beverage: $2,624Education: $155
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $383 |
| Janssen Biotech, Inc. | 8 | $262 |
| GlaxoSmithKline, LLC. | 10 | $212 |
| BeOne Medicines USA, Inc. | 8 | $208 |
| ABBVIE INC. | 9 | $177 |
| Stemline Therapeutics Inc. | 7 | $146 |
| TerSera Therapeutics LLC | 5 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $125 |
| Daiichi Sankyo Inc. | 4 | $80 |
| Incyte Corporation | 3 | $72 |
Products named: Enhertu, ERLEADA, TEVIMBRA, Orserdu, LIBTAYO, BRUKINSA, JEMPERLI, RYBREVANT.
Industry payments across WA — which companies pay providers there.
